Skip to Main Content

Author Details

Haran Sivakumaran
QIMR Berghofer Medical Research Institute
2005
32
16
PMIDPaper TitleJournal TitlePublished Year
36713455CRISPR interference for sequence-specific regulation of fibroblast growth factor receptor A in <i>Schistosoma mansoni</i>.Front Immunol2023
36713455CRISPR interference for sequence-specific regulation of fibroblast growth factor receptor A in <i>Schistosoma mansoni</i>.Front Immunol2023
37333134Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179.Res Sq2023
36991492CRISPR screens identify gene targets at breast cancer risk loci.Genome Biol2023
37487416Development of CRISPR/Cas13a-based assays for the diagnosis of Schistosomiasis.EBioMedicine2023
37487416Development of CRISPR/Cas13a-based assays for the diagnosis of Schistosomiasis.EBioMedicine2023
36991492CRISPR screens identify gene targets at breast cancer risk loci.Genome Biol2023
37333134Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179.Res Sq2023
33337558CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase.FASEB J2021
33337558CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase.FASEB J2021
32871102eQTL Colocalization Analyses Identify NTN4 as a Candidate Breast Cancer Risk Gene.Am J Hum Genet2020
31910864Non-coding RNAs underlie genetic predisposition to breast cancer.Genome Biol2020
31910858Chromatin interactome mapping at 139 independent breast cancer risk signals.Genome Biol2020
32871102eQTL Colocalization Analyses Identify NTN4 as a Candidate Breast Cancer Risk Gene.Am J Hum Genet2020
31910864Non-coding RNAs underlie genetic predisposition to breast cancer.Genome Biol2020
31910858Chromatin interactome mapping at 139 independent breast cancer risk signals.Genome Biol2020
29541943Differential Effects of Strategies to Improve the Transduction Efficiency of Lentiviral Vector that Conveys an Anti-HIV Protein, Nullbasic, in Human T Cells.Virol Sin2018
29541943Differential Effects of Strategies to Improve the Transduction Efficiency of Lentiviral Vector that Conveys an Anti-HIV Protein, Nullbasic, in Human T Cells.Virol Sin2018
28777932Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA Damage.Am J Hum Genet2017
28777932Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA Damage.Am J Hum Genet2017
26840454Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.Oncotarget2016
26840454Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.Oncotarget2016
26928228Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.Nat Genet2016
27381288Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.mBio2016
27087319Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.Am J Hum Genet2016
27259051A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding.Am J Hum Genet2016
26611710The protein arginine methyltransferase PRMT6 inhibits HIV-1 Tat nucleolar retention.Biochim Biophys Acta2016
27640304Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.Am J Hum Genet2016
26611710The protein arginine methyltransferase PRMT6 inhibits HIV-1 Tat nucleolar retention.Biochim Biophys Acta2016
27640304Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.Am J Hum Genet2016
27259051A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding.Am J Hum Genet2016
27381288Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.mBio2016
27087319Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.Am J Hum Genet2016
26928228Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.Nat Genet2016
25673710A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex.J Virol2015
25673710A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex.J Virol2015
26624286Specific Interaction between eEF1A and HIV RT Is Critical for HIV-1 Reverse Transcription and a Potential Anti-HIV Target.PLoS Pathog2015
26624286Specific Interaction between eEF1A and HIV RT Is Critical for HIV-1 Reverse Transcription and a Potential Anti-HIV Target.PLoS Pathog2015
24887313Synergistic activity of tenofovir and nevirapine combinations released from polycaprolactone matrices for potential enhanced prevention of HIV infection through the vaginal route.Eur J Pharm Biopharm2014
25496916A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1.Retrovirology2014
24867411Evaluation of polycaprolactone matrices for sustained vaginal delivery of nevirapine in the prevention of heterosexual HIV transmission.J Pharm Sci2014
24887313Synergistic activity of tenofovir and nevirapine combinations released from polycaprolactone matrices for potential enhanced prevention of HIV infection through the vaginal route.Eur J Pharm Biopharm2014
25496916A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1.Retrovirology2014
24867411Evaluation of polycaprolactone matrices for sustained vaginal delivery of nevirapine in the prevention of heterosexual HIV transmission.J Pharm Sci2014
23298160A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells.Hum Gene Ther2013
23904196An evaluation of polycaprolactone matrices for vaginal delivery of the antiviral, tenofovir, in preventing heterosexual transmission of HIV.J Pharm Sci2013
23800116Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6.Virol J2013
23298160A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells.Hum Gene Ther2013
23904196An evaluation of polycaprolactone matrices for vaginal delivery of the antiviral, tenofovir, in preventing heterosexual transmission of HIV.J Pharm Sci2013
23800116Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6.Virol J2013
  • 1 - 50 of 64

Recommended Authors

Icahn School of Medicine at Mount Sinai, Duke-NUS Medical School
Career Start Year 2012
Number of shared co-authors 0
University Hospital of Wurzburg
Career Start Year 2012
Number of shared co-authors 0
Gladstone Institutes
Career Start Year 2010
Number of shared co-authors 0
VIB-KU Leuven Center for Cancer Biology
Career Start Year 2010
Number of shared co-authors 2
Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Drexel University College of Medicine
Career Start Year 2007
Number of shared co-authors 0
University of California San Diego
Career Start Year 2007
Number of shared co-authors 0
National Institute of Molecular Genetics, "Fondazione Romeo ed Enrica Invernizzi"
Career Start Year 2005
Number of shared co-authors 0
Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes
Career Start Year 2004
Number of shared co-authors 1
Universite Cote d'Azur, CNRS UMR5
Career Start Year 2004
Number of shared co-authors 0
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2003
Number of shared co-authors 0
Albert Einstein College of Medicine
Career Start Year 2002
Number of shared co-authors 0
University of California davis
Career Start Year 2002
Number of shared co-authors 0
The Scripps Research Institute
Career Start Year 2001
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 0
Erasmus University Medical Center
Career Start Year 1999
Number of shared co-authors 0
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 0
University of Texas Southwestern Medical Center
Career Start Year 1998
Number of shared co-authors 0
University of Massachusetts Medical School
Career Start Year 1995
Number of shared co-authors 0
University of California at San Francisco
Career Start Year 1994
Number of shared co-authors 0
Gladstone Institute of Virology
Career Start Year 1993
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 0
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 0
University of Utah
Career Start Year 1991
Number of shared co-authors 0
Altius Institute for Biomedical Sciences
Career Start Year 1990
Number of shared co-authors 0
Institute for Genomic Medicine, University of California San Diego
Career Start Year 1990
Number of shared co-authors 0
Merck & Co., Inc.
Career Start Year 1989
Number of shared co-authors 0
University of British Columbia
Career Start Year 1984
Number of shared co-authors 0
Buck Institute for Research on Aging
Career Start Year 1983
Number of shared co-authors 2
University of California at San Francisco
Career Start Year 1978
Number of shared co-authors 0

Collaborators

QIMR Berghofer Medical Research Institute
Co-authored papers 14
QIMR Berghofer Medical Research Institute
Co-authored papers 11
QIMR Berghofer Medical Research Institute
Co-authored papers 8
QIMR Berghofer Medical Research Institute
Co-authored papers 8
QIMR Berghofer Medical Research Institute
Co-authored papers 6
QIMR Berghofer Medical Research Institute
Co-authored papers 5
Co-authored papers 5
University of Cambridge
Co-authored papers 5
Otto-Friedrich-University Bamberg
Co-authored papers 3
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 3
QIMR Berghofer Medical Research Institute
Co-authored papers 3
Co-authored papers 3
Instituto de Salud Carlos III
Co-authored papers 2
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 2
Faculty of Clinical Medicine, University of Oslo
Co-authored papers 2
The Usher Institute, The University of Edinburgh
Co-authored papers 2
The Netherlands Cancer Institute
Co-authored papers 2
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
University of California irvine
Co-authored papers 2
Mayo Clinic College of Medicine
Co-authored papers 2
Co-authored papers 2
QIMR Berghofer Medical Research Institute
Co-authored papers 2
University of Utah
Co-authored papers 2
German Cancer Research Center (DKFZ)
Co-authored papers 2
University of Southern California
Co-authored papers 2
University of Queensland
Co-authored papers 2
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Neaman Center for Personalized Medicine, NorthShore University HealthSystem
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
Co-authored papers 2